Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hartlapp

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|May 1, 1995
[Side effects and complications of intra-arterial tumor therapy--experiences with 577 interventions]J Görich, I Hasan, H Sittek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSFM Engelhard, H Gerhartz, G Brittinger, et al.
Klinische Wochenschrift|February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvumD Fritze, B Massner, R Becher, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|May 1, 1995
[Side effects and complications of intra-arterial tumor therapy--experiences with 577 interventions]J Görich, I Hasan, H Sittek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSFM Engelhard, H Gerhartz, G Brittinger, et al.
Klinische Wochenschrift|February 15, 1984
Combination chemotherapy (VAC/FMC) with immunostimulation in metastatic breast cancer: a randomized study comparing different times and routes of administration of Corynebacterium parvumD Fritze, B Massner, R Becher, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2001
Remission induction therapy: the more intensive the better?T Büchner, W Hiddemann, W Berdel, et al.
Der Urologe. Ausg. A|September 27, 2003
[Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany]J Lehmann, M Retz, G Steiner, et al.
Pageof 4